Celtic Lux Holdings Acquires 10.1 Million Alvotech Shares at $3.75 Each

GlobeNewswire··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Celtic Lux Holdings S.a. r.l., formerly known as Alvogen Lux Holdings S.a. r.l., acquired 10,133,333 shares in Alvotech at a price of USD 3.75 per share. The transaction, disclosed in a filing with the Luxembourg Commission de Surveillance du Secteur Financier, took place on June 16, 2026.

Impact on assets 1

Biotech & Genomic Medicine▲
Alvotech
ALVO
▲ PositiveCapitalrelevance

Celtic Lux Holdings acquired 10.1 million shares at $3.75 each, signaling insider confidence and providing capital support.

Off-coverage companies 1

Celtic Lux Holdings S.a r.l.i
Private± MixedCapitalrelevance

Celtic Lux Holdings is the acquirer, but the impact on the holding company itself is unclear from the transaction alone.